no dramatic growth
Printable View
This is a company that has a product I really believe in but has repeatedly failed to deliver. They have become more professional and organised in recent years but they are a lot better at the technical/product side of things than the marketing and management.
I will hang in there for now...
Is this a disappointing result for some? Interested to see what people's expectations of today were
Performance Overview.
I am pleased to report that 2020 saw Blis continue to deliver against the objectiveof producing sustainable profitable growth.
Our revenues were up 29% for the year, providing a 33% CAGR over the last 5years and our EBITDA of $2.1m was up 130% on last year.
Sorry, left off the below for the quarter**
Unaudited results for the quarter ending 30 June 2020
Total revenue for the quarter $ 2.9m (Q1 FY21). ($2.7m for Q1 FY20)
EBITDA surplus $ 0.4m ($0.5m for Q1 FY20)
No dramatic growth and no plans for dividend. Didn't know what I expected.
We all knew the 2020 results. The key for many was the Q1 results which were rather flat.
The question remains though, how does the impact of Covid affect this number? Should it be increasing demand? Or do people purchase less with more people being made redundant etc.
Personally, I find the Amazon and TMall (China) aspect VERY interesting. Alibaba/China offer a massive opportunity.
I've sold 80% but will keep an eye on them
Was expecting a double digit growth for the quarter of at least 25-30%, instead they've grown in single digits. Hopefully they can pick up growth soon, until then happy to watch from sidelines.
I am listening to the AGM online. Sounds like Europe/ Middle east "hit hard"by Covid as most business via pharmacies. But North America online growth is continuing to grow.
So main focus is on Online sales channels specifically in USA, China and Canada.
Based on that I think the FY21 forecast is conservative especially with the Skin probiotic launch. The reason to be conservative is the increased costs of airfreight and uncertainty on supply routes (although Brian said this is being managed, just needs continued focus)
so not too bad from my perspective
I agree, I think listening to the AGM the Q1 results don't sound as bad as it looks.
One to hold for me.
Coronavirus should have pushed demand into the stratosphere. In most countries chemists, which is a natural sales channel for these products, remained open during lockdown.
Mail order for health related products boomed during lockdown in most countries.
Iherb were consistently selling out of stock, especially of probiotics and anything immune related. Iherb shipped throughout lockdown. Amazon prioritised customers and had some delays but they experienced massive demand. I expect it’s the same for other online sellers.
There may have been some delay in delivering to some markets but I expected a bigger uptick in sales. A dividend would be nice but wasn’t expected.
I’m pleased there was some growth but given the new markets and channels it seems flat to me.
Am online as well. The focus on Alibaba distribution is good...interesting to hear CEO's expansion of his thoughts around this, and that sounds like a way into the CHinese/Asian market for them. Like the fact they are using their additional revenue growth to 'invest' in longer term market entries. Going into cosmetics - they'll need that! Whole different capability, but one that provides a good leg of future growth.
Not worried about Q1 sales - still good growth, company is investing for the long term and seems to be 'pacing' /prioritising growth in line with development of its own internal capabilities.
Disc: hold, probably about to buy more after this.
I think my 7.9-8.1c range at close Friday was too optimistic
The market isn't excited about the update.
Not surprising given that the investment into new markets and the global uncertainty leaves a lot of questions about future performance.
I am not as bullish as BLT about the expiring patents but I am excited about the new products. Skincare done right could be a winner
Revenue slightly down on what i was expecting but with covid disruption im prepared to overlook it.thoughts?